UK Markets closed

4D pharma plc (DDDD.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
16.66+0.80 (+5.04%)
At close: 06:11PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.95
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 377.00
52-week low 30.00
50-day moving average 32.81
200-day moving average 315.82

Share statistics

Avg vol (3-month) 318.58k
Avg vol (10-day) 3N/A
Shares outstanding 5180.3M
Implied shares outstanding 6N/A
Float 8134.29M
% held by insiders 120.38%
% held by institutions 127.47%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-5,125.63%

Management effectiveness

Return on assets (ttm)-42.64%
Return on equity (ttm)-89.48%

Income statement

Revenue (ttm)718k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-12.00%
Gross profit (ttm)718k
EBITDA -35.45M
Net income avi to common (ttm)-31.94M
Diluted EPS (ttm)-19.20
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.97M
Total cash per share (mrq)0.12
Total debt (mrq)12.8M
Total debt/equity (mrq)39.50
Current ratio (mrq)5.21
Book value per share (mrq)0.30

Cash flow statement

Operating cash flow (ttm)-37.92M
Levered free cash flow (ttm)-28.03M